October 8, 2014
Siamab Therapeutics Appoints Robert Mashal to Board of Directors; Receives SBIR grant focused on cancer stem cells; Research to be conducted in collaboration with Massachusetts General Hospital

July 10, 2014
Sialix Changes Name to Siamab Therapeutics, Inc.; Additional $2M Raised Bringing Series B Total To $6 Million

February 5, 2014
Sialix Closes Oversubscribed Second Tranche of Series B Financing

July 30, 2013
Sialix Raises $1.0 Million in Second Round of Series B Financing

December 4, 2012
Sialix Forms Scientific Advisory Board and Business Advisory Board; Sialix research operations to be located at Janssen Labs at San Diego

October 4, 2012
Sialix Executes Option Agreement; Appoints New Management Team to Advance Sialic Acid-Based Products for Treatment and Prevention of Cancer and Inflammation

April 19, 2011
Potential New Blood Test and Treatment for Breast Cancer Announced by Sialix, Inc. And Researchers at The University of California, San Diego